Keywords: Sheffield Bio-Science, Wockhardt, Wosulin, Recombinant insulin
Sheffield Bio-Science to distribute Wockhardt’s recombinant insulin to cell culture market
Article | 22 February 2011
India’s Wockhardt (BSE: WOCK) says that it has formed a strategic alliance with Sheffield Bio-Science, a subsidiary of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
